Reports are published which analyse drug-related deaths that have occurred in a calendar year and cover trends and data on drug-related deaths including accidental or intentional deaths from prescription medications, recreational drugs such as cocaine and MDMA, deaths resulting from long-term drug use including complications as a result of intravenous heroin use, and novel psychoactive substances or ’legal highs’. Data available includes:
demographic information about decedents
geographic areas in which they occurred
toxicology test results showing substances found at post mortem
types of medication known to be prescribed to decedents
the cause(s) of death
the coroner’s verdict.
The NPSAD team currently provide, on request, anonymised data, further analysis and enhanced information about deaths for policy makers, members of parliament, the Advisory Council on Misuse of Drugs, the European Monitoring Centre for Drugs and Drug Addiction, the UK Drugs Early Warning System, Public Health England and drug action teams, amongst others.
Contacting the NPSAD
For further details and potential costings please contact the NPSAD team. There are two ways to do this:
For academic publications in 2020 and earlier, please contact us via the above methods.
NPSAD data collection is unaffected by the General Data Protection Regulation (GDPR) (EU) 2016/679 due to the regulation only applying to the personal data of living individuals.
Data tables for deaths in Northern Ireland in 2015 and England in 2016 onward will be published in due course. Please contact us for preliminary data.
The NPSAD team can provide further analysis and enhanced information about deaths for Drug Action Teams, Primary Care Trusts, Special Health Authorities and others. For further details or for reports from years prior to 2011, please contact email@example.com